Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE238.4100
- TODAY'S CHANGE (%)5.4100 (2.3219%)
- Bid / Lots236.8700/ 2
- Ask / Lots238.2300/ 1
- Open / Previous Close230.2000 / 233.0000
- Day Range
- 52 Week Range
- Volume35,656
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 2648 | 230.2 |
| 09:34 ET | 200 | 232.66 |
| 09:36 ET | 145 | 230.64 |
| 09:38 ET | 100 | 231.33 |
| 09:41 ET | 100 | 231.635 |
| 09:43 ET | 224 | 232 |
| 09:48 ET | 400 | 232.85 |
| 09:52 ET | 1696 | 233.11 |
| 09:56 ET | 100 | 231.47 |
| 09:59 ET | 340 | 232.175 |
| 10:01 ET | 350 | 232.28 |
| 10:08 ET | 232 | 231.79 |
| 10:10 ET | 203 | 231.125 |
| 10:14 ET | 100 | 231.355 |
| 10:15 ET | 100 | 231.41 |
| 10:17 ET | 618 | 230.0183 |
| 10:21 ET | 1300 | 230.51 |
| 10:24 ET | 1599 | 232.19 |
| 10:26 ET | 100 | 231.86 |
| 10:30 ET | 1100 | 232.595 |
| 10:32 ET | 200 | 232.45 |
| 10:35 ET | 100 | 232.9 |
| 10:39 ET | 1500 | 232.83 |
| 10:42 ET | 200 | 233.305 |
| 10:50 ET | 100 | 233.5322 |
| 10:51 ET | 100 | 232.9 |
| 10:53 ET | 100 | 232.9 |
| 10:57 ET | 200 | 233.33 |
| 11:02 ET | 100 | 232.305 |
| 11:15 ET | 200 | 233.48 |
| 11:22 ET | 200 | 233.4275 |
| 11:44 ET | 100 | 234.95 |
| 11:45 ET | 100 | 234.515 |
| 11:56 ET | 100 | 234.305 |
| 12:03 ET | 100 | 234.28 |
| 12:20 ET | 400 | 234.71 |
| 12:25 ET | 100 | 234.46 |
| 12:32 ET | 200 | 234.825 |
| 12:38 ET | 200 | 235.705 |
| 12:39 ET | 585 | 235.835 |
| 12:41 ET | 400 | 236.83 |
| 12:43 ET | 100 | 236.465 |
| 12:54 ET | 200 | 236.885 |
| 12:56 ET | 300 | 237.18 |
| 12:57 ET | 309 | 237.19 |
| 01:03 ET | 800 | 238.41 |
Aug 26, 2024
Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 8:00AM ET on Monday Aug 26, 2024 by Dow Jones
8:00AM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 5.1B | -9.4x | --- |
BridgeBio Pharma Inc | 5.3B | -10.5x | --- |
Avidity Biosciences Inc | 4.7B | -14.0x | --- |
Nuvalent Inc | 5.5B | -29.3x | --- |
Immunovant Inc | 4.3B | -14.9x | --- |
Krystal Biotech Inc | 5.7B | 55.3x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- General Counsel
- Shannon Kelley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.1B |
|---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.41 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -9.4x |
Price/Sales (TTM) | 345.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
